Showing results (1651-1660 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|April 1, 2015
Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphomaAnnegret Reichwagen, Marita Ziepert, Markus Kreuz, et al.
Pharmacogenomics|April 1, 2015
Evaluation of association studies and meta-analyses of MTHFR gene polymorphisms in colorectal cancerBatoul Sadat Haerian, Monir Sadat Haerian
Pharmacogenomics|February 26, 2015
Genetic polymorphism in ATG16L1 gene influences the response to adalimumab in Crohn's disease patientsSilvo Koder, Katja Repnik, Ivan Ferkolj, et al.
Pharmacogenomics|April 2, 2015
Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene studyAbiy Habtewold, Eyasu Makonnen, Wondwossen Amogne, et al.
Pharmacogenomics|May 1, 2023
Patient satisfaction with return of pharmacogenomic results utilizing a patient portal messageJoel Van Heukelom, Kristen Jacobsen, Natasha J Petry, et al.
Pharmacogenomics|May 24, 2023
The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosingKhalifa Alrajeh, Ola AlAzzeh, Youssef Roman
Pharmacogenomics|June 24, 2014
Exploring effects of EAAT polymorphisms on cognitive functions in schizophreniaMarco Spangaro, Marta Bosia, Andrea Zanoletti, et al.
Pharmacogenomics|June 24, 2014
Polymorphisms in translesion polymerase genes influence treatment outcome in malignant mesotheliomaKatja Goričar, Viljem Kovač, Vita Dolžan
Pharmacogenomics|July 24, 2020
Gene-wise variant burden and genomic characterization of nearly every geneYoomi Park, Heewon Seo, Brian Y Ryu, et al.
Pharmacogenomics|July 4, 2020
The influence of coffee intake and genetics on adenosine pathway in rheumatoid arthritisTomáš Soukup, Karel Hloch, Martin Doseděl, et al.
Pageof 276